Emtricitabine and tenofovir and Ibritumomab Intravenous
Determining the interaction of Emtricitabine and tenofovir and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and Tenofovir Disoproxil Fumarate
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine and tenofovir-Ibritumomab Tiuxetan
- Emtricitabine and tenofovir-Ibrutinib
- Emtricitabine and tenofovir-Ibrutinib Capsules
- Emtricitabine and tenofovir-Ibrutinib Tablets
- Emtricitabine and tenofovir-Ibu
- Emtricitabine and tenofovir-IBU Tablets
- Ibritumomab Intravenous-Emtricitabine and Tenofovir Alafenamide
- Ibritumomab Intravenous-Emtricitabine and Tenofovir Disoproxil Fumarate
- Ibritumomab Intravenous-Emtricitabine and Tenofovir Tablets
- Ibritumomab Intravenous-Emtricitabine Capsules
- Ibritumomab Intravenous-Emtricitabine Solution
- Ibritumomab Intravenous-Emtricitabine, lopinavir, ritonavir, and tenofovir